Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2

Hepatology

Volumn 36, Issue 3, 2002, Pages 615-622

  Preaux, Anne Marie ^a   D'Ortho, Marie Pia ^b   Bralet, Marie Pierre ^a   Laperche, Yannick ^a   Mavier, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CERAMIDE; CYTOCHALASIN D; DNA; GELATINASE A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; FIBROGENESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER DISEASE; LIVER FIBROSIS; MYOFIBROBLAST; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0036730388     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35279     Document Type: Article

References (49)

1. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
2. Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential
3. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat
4. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
5. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats
6. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection
7. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
8. Matrix metalloproteinases
9. Pathogenesis of liver fibrosis
10. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride
11. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver
12. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers
13. Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture
14. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis
15. A matrix metalloproteinase expressed on the surface of invasive tumour cells
16. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
17. MT1-MMP on the cell surface causes focal degradation of gelatin film
18. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A
19. Mitogenic effect of transforming growth factor-β1 on human Ito cells in culture: Evidence for mediation by endogenous platelet-derived growth factor
20. Antiproliferative Properties of Sphingosine 1-Phosphate in Human Hepatic Myofibroblasts. A cyclooxygenase-2 mediated pathway
21. Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion
22. Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3
23. Matrix metalloproteinase-2 activation in human hepatic fibrosis. Regulation by cell-matrix interactions
24. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
25. Caspases: Enemies within
26. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes
27. Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes
28. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153
29. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
30. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
31. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2
32. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propetide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3
33. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases
34. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP-2 activation in injured human livers
35. Disruption of actin microfilament by cytochalasin D leads to activation of p53
36. Cytoskeletal disruption induces T cell apoptosis by a caspase-3 mediated mechanism
37. Ceramide and apoptosis
38. The pharmacology of apoptosis
39. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases
40. Role of acidic sphingomyelinase in Fas/CD95-mediated cell death
41. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton
42. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MTMMP)
43. Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage
44. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways
45. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form
46. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate
47. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure
48. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway
49. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases